{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:41:24Z","timestamp":1792784484598,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Maslah Saul Chair"},{"name":"James & Carrie Anderson Fund for Epilepsy"},{"name":"Susan Horngren Fund"},{"name":"Littlefield Fund"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.yebeh.2014.09.060","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T19:18:57Z","timestamp":1416511137000},"page":"140-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["The Personal Impact of Epilepsy Scale (PIES)"],"prefix":"10.1016","volume":"42","author":[{"given":"Robert S.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Nune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanford E.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce A.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2014.09.060_bb0005","first-page":"1","article-title":"A technique for the measurement of attitudes","volume":"140","author":"Likert","year":"1932","journal-title":"Arch Psychol"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0010","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0896-6974(98)00027-9","article-title":"Seizure measurement in clinical trials","volume":"11","author":"Cramer","year":"1998","journal-title":"J Epilepsy"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2010.04.001","article-title":"Measuring outcomes of treatment with antiepileptic drugs in clinical trials","volume":"18","author":"Ben-Menachem","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0020","series-title":"Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims","author":"FDA","year":"2009"},{"issue":"Suppl. 3","key":"10.1016\/j.yebeh.2014.09.060_bb0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1528-1157.2001.042suppl.3066.x","article-title":"Assessment of quality of life in people with epilepsy: some practical implications","volume":"42","author":"Baker","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1477-7525-11-38","article-title":"Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirements","volume":"11","author":"Nixon","year":"2013","journal-title":"Health Qual Life Outcomes"},{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2014.09.060_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1528-1167.2006.00666.x","article-title":"Epilepsy-related injuries","volume":"47","author":"Wirrell","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0920-1211(91)90071-M","article-title":"The development of a seizure severity scale as an outcome measure in epilepsy","volume":"8","author":"Baker","year":"1991","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.33.3_Suppl_1.26","article-title":"A method of quantification for the evaluation of antiepileptic drug therapy","volume":"33","author":"Cramer","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0050","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1528-1157.1996.tb00610.x","article-title":"The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale","volume":"37","author":"O'Donoghue","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0920-1211(96)00013-7","article-title":"Outcome assessment in epilepsy: available rating scales for adults and methodological issues pertaining to the development of scales for childhood epilepsy","volume":"24","author":"Carpay","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1528-1157.2001.19400.x","article-title":"Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components","volume":"42","author":"Cramer","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.yebeh.2013.10.010","article-title":"Sensitivity testing of the Seizure Severity Questionnaire (SSQ)","volume":"31","author":"Borghs","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0070","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/ern.10.71","article-title":"Adverse effects of antiepileptic drugs: a brief overview of important issues","volume":"10","author":"Cramer","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.62.1.23","article-title":"Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial","volume":"62","author":"Gilliam","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic\u2013clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0085","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199209103271104","article-title":"A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic\u2013clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group","volume":"327","author":"Mattson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0404.2010.01440.x","article-title":"Non-interventional surveillance study of adverse events in patients with epilepsy","volume":"124","author":"Cramer","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1059-1311(98)80036-8","article-title":"Liverpool Seizure Severity Scale revisited","volume":"7","author":"Baker","year":"1998","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0100","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1528-1167.2006.00956.x","article-title":"The Liverpool Adverse Events Profile: relation to AED use and mood","volume":"48","author":"Panelli","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0105","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.0013-9580.2005.66104.x","article-title":"Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0920-1211(93)90042-6","article-title":"Measuring the impact of epilepsy: the development of a novel scale","volume":"16","author":"Jacoby","year":"1993","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yebeh.2012.11.046","article-title":"The reliability and validity of the Revised Liverpool Impact of Epilepsy Scale for use in people with new-onset epilepsy","volume":"26","author":"Crossley","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1525-5050(02)00533-4","article-title":"Mood disorders are linked to health-related quality of life in epilepsy","volume":"3","author":"Cramer","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0125","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ana.410370205","article-title":"Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life","volume":"37","author":"Vickrey","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0130","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1212\/WNL.53.1.162","article-title":"Seizure frequency and the health-related quality of life of adults with epilepsy","volume":"53","author":"Leidy","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0135","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.53.4.687","article-title":"Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy","volume":"53","author":"Gilliam","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0140","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1528-1157.1995.tb00467.x","article-title":"Development of the quality of life in epilepsy inventory","volume":"36","author":"Devinsky","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","article-title":"Development and cross-cultural translation of a 31-item quality of life inventory (QOLIE-31)","volume":"39","author":"Cramer","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.yebeh.2011.12.023","article-title":"Defining minimally important change in QOLIE-31 scores: estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures","volume":"23","author":"Borghs","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0155","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","article-title":"Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory","volume":"39","author":"Cramer","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","article-title":"Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation","volume":"8","author":"Beck","year":"1988","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0170","unstructured":"Epilepsy Foundation. Depression: A checklist. Available at: http:\/\/old.epilepsyfoundation.org\/about\/related\/depression\/depressioncheck.cfm#.VDWFLYd0wUQ."},{"key":"10.1016\/j.yebeh.2014.09.060_bb0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0920-1211(02)00003-7","article-title":"Development of a new seizure severity questionnaire: initial reliability and validity testing","volume":"48","author":"Cramer","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02310555","article-title":"Coefficient alpha and the internal structure of tests","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0185","series-title":"Cronbach alpha (v1.0.3) in Free Statistics Software (v1.1.23-r7)","author":"Wessa","year":"2014"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0190","series-title":"Statistics Calculators, version 3.0, p-value calculator for correlation coefficients","author":"Soper","year":"2014"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0200","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1469-8749.2003.tb00923.x","article-title":"Assessing the impact of pediatric epilepsy and concomitant behavioral, cognitive, and physical\/neurologic disability: Impact of Childhood Neurologic Disability Scale","volume":"45","author":"Camfield","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0205","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0920-1211(96)00012-5","article-title":"Parent-completed scales for measuring seizure severity and severity of side-effects of antiepileptic drugs in childhood epilepsy: development and psychometric analysis","volume":"24","author":"Carpay","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1469-8749.1997.tb07480.x","article-title":"Disability due to restrictions in childhood epilepsy","volume":"39","author":"Carpay","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0215","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yebeh.2013.12.030","article-title":"The Impact on Family Scale: psychometric analysis of long and short forms in parents of children with epilepsy","volume":"32","author":"Dehn","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.yebeh.2004.01.010","article-title":"The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy","volume":"5","author":"Cramer","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0225","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.yebeh.2003.07.009","article-title":"The influence of comorbid depression on quality of life for people with epilepsy","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0230","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.0013-9580.2003.28403.x","article-title":"The influence of comorbid depression on seizure severity","volume":"44","author":"Cramer","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9150","article-title":"Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation","volume":"9","author":"Wilby","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0240","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1528-1157.1998.tb01446.x","article-title":"Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy","volume":"39","author":"Kline Leidy","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0245","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1528-1157.1997.tb01732.x","article-title":"Outcome assessment in epilepsy: comparative responsiveness of quality of life and psychosocial instruments","volume":"38","author":"Wiebe","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0250","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.yebeh.2013.09.006","article-title":"Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ)","volume":"31","author":"Cramer","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0255","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.yebeh.2011.08.035","article-title":"An online diary for tracking epilepsy","volume":"22","author":"Le","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2014.09.060_bb0260","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1651-2227.2010.01694.x","article-title":"Tracking epilepsy with an electronic diary","volume":"99","author":"Fisher","year":"2010","journal-title":"Acta Paediatr"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501400496X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501400496X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T12:51:53Z","timestamp":1566046313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501400496X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":52,"alternative-id":["S152550501400496X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.09.060","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Personal Impact of Epilepsy Scale (PIES)","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2014.09.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}